PATTERNS OF TREATMENT ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING LINAGLIPTIN AND OTHER NON-INSULIN DIABETES MEDICATIONS (NIDMS)

被引：0
|
作者：
Patorno, E. [1 ,2 ]
Gopalakrishnan, C. [1 ,2 ]
Zorina, O. [3 ]
Schneeweiss, S. [1 ,2 ]
Bartels, D. [3 ]
Seeger, J. D. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.335
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB28
引用
收藏
页码：A57 / A57
页数：1
相关论文
共 50 条
  • [41] HOW DIFFERENT WERE THEY? A TREATMENT PATTERN ANALYSIS OF UNITED STATES PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING INJECTABLE THERAPY
    Walker, V
    Wei, W.
    Thayer, S.
    Brekke, L.
    Crown, W.
    Grabner, M.
    Raparla, S.
    Quimbo, R.
    Cziraky, M.
    Hu, W.
    Cuddihy, R.
    VALUE IN HEALTH, 2012, 15 (07) : A493 - A493
  • [42] Association between Hypoglycemia and Medication Adherence among Veterans With Type 2 Diabetes Mellitus (T2DM)
    Zhao, Yingnan
    Campbell, Claudia
    Fonseca, Vivian
    Shi, Lizheng
    DIABETES, 2012, 61 : A553 - A553
  • [43] Risk Factors and Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Basal Insulin in a US Managed Care System
    Chou, Engels
    Chung, Hsing-Wen
    Wang, Hongwei
    DIABETES, 2014, 63 : A66 - A67
  • [44] Consideration of Comorbidities in Treatment Choice for Patients with Type 2 Diabetes (T2DM)
    Ritchey, Mary E.
    Engel, Samuel S.
    Liu, Zhiwen
    Ntabadde, Catherine
    Senderak, Michael
    Shankar, Ravi
    Qiu, Ying
    Radican, Larry
    Rajpathak, Swapnil
    Brodovicz, Kimberly G.
    DIABETES, 2014, 63 : A636 - A636
  • [45] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)
    Johns, D
    Herz, M
    Tan, MH
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    DIABETES, 2002, 51 : A102 - A102
  • [46] Reasons for Non-Treatment of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in the United Kingdom
    Marrett, Elizabeth
    Jameson, Kevin
    Zhang, Qiaoyi
    Meiler, Susanne
    Radican, Larry
    Sinclair, Alan
    DIABETES, 2010, 59 : A293 - A294
  • [47] Perception of Type 2 Diabetes Mellitus (T2DM) patients on diabetes self-care management in Fiji
    Kumar, Reshma
    Mohammadnezhad, Masoud
    Khan, Sabiha
    PLOS ONE, 2024, 19 (05):
  • [48] Type 2 Diabetes Mellitus (T2DM) "Remission" in Non-bariatric Patients 65 Years and Older
    Tangelloju, Srikanth
    Little, Bert B.
    Esterhay, Robert J.
    Brock, Guy
    LaJoie, A. Scott
    FRONTIERS IN PUBLIC HEALTH, 2019, 7
  • [49] THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND
    Kolasa, K.
    Niewada, M.
    de Troconiz, J. Puelles Fernandez
    Townsend, R.
    McEwan, P.
    VALUE IN HEALTH, 2010, 13 (07) : A290 - A290
  • [50] Predictors of switching to insulin from non-insulin therapy in patients with type 2 diabetes mellitus
    Janghorban, Mohsen
    Amini, Masoud
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (01) : 111 - 117
12345